GRANULES vs HALEOSLABS: Stock Comparison

Granules India Limited vs Haleos Labs Limited

Live data: 22 July 2026, 3:05 PM IST • Source: NSE and company filings

Granules India Limited is the larger company by market capitalisation. Granules India Limited shows a higher ROE, a higher dividend yield and faster revenue growth, while Haleos Labs Limited shows a lower P/E. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Side-by-side comparison of Granules India Limited and Haleos Labs Limited on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.

On standard readings, GRANULES is more favourable on 10 of 13 scored metrics and HALEOSLABS on 3These counts are context-free and are not an overall rating.

Key Differences

Market Cap
GRANULES is the larger company
₹21,158 Cr vs ₹484 Cr
P/E Ratio
HALEOSLABS has a lower P/E
27.94x vs 36.28x
P/B Ratio
HALEOSLABS has a lower P/B
2.27x vs 4.24x
EPS
HALEOSLABS has higher earnings per share
₹57.3 vs ₹24.44
Dividend Yield
GRANULES has a higher dividend yield
0.2% vs 0.1%
Revenue Growth (TTM YoY)
GRANULES has faster revenue growth
22.8% vs 0%
EPS Growth (TTM YoY)
GRANULES has faster EPS growth
31.3% vs 0%
Qtr Sales Growth
GRANULES has stronger quarterly sales growth
22.8% vs -15.7%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricGRANULESHALEOSLABS
SectorHealthcare
IndustryPharmaceuticals

Price

MetricGRANULESHALEOSLABS
Live Price₹853.85₹1,522.4
Day Change-2.5%-3.09%
Volume14.52 L281
52-Week High₹910₹1,774
52-Week Low₹432.6₹1,181
Distance from 52W High-6.17%-14.18%

Valuation

MetricGRANULESHALEOSLABS
Market Cap₹21,158 Cr₹484 Cr
P/E Ratio36.28x27.94x
P/B Ratio4.24x2.27x
EPS₹24.44₹57.3
Book Value₹205.21₹706
Dividend Yield0.2%0.1%

Growth

MetricGRANULESHALEOSLABS
Revenue Growth (TTM YoY)22.8%0%
EPS Growth (TTM YoY)31.3%0%
Qtr Sales Growth22.8%-15.7%
Qtr Profit Growth44.6%-85.2%

Profitability & Leverage

MetricGRANULESHALEOSLABS
ROE13.7%8.44%
ROCE15.5%9.91%
Net Margin11.15%5.33%
Operating Margin22.1%13.4%
Debt to Equity0.3x0.52x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricGRANULESHALEOSLABS
Promoter Holding37.67%72.11%
FII Holding17.5% 2.19 pp0%
DII Holding16.11% 0.9 pp0.31% 0.01 pp
Public Holding28.38% 1.28 pp27.58% 0.02 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Granules India Limited and Haleos Labs Limited.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.